TIAA CREF Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$20.5M	Buy	763,896 +332,582	+77%	+$7.77M	0.01%	701
2018 Q4	$6.97M	Sell	431,314 -134,360	-24%	-$2.61M	0.01%	1160
2018 Q3	$11.7M	Buy	565,674 +15,850	+3%	+$249K	0.01%	1020
2018 Q2	$8.4M	Buy	549,824 +102,385	+23%	+$1.83M	0.01%	1264
2018 Q1	$10.1M	Sell	447,439 -161,061	-26%	-$4.46M	0.01%	1113
2017 Q4	$18.3M	Sell	608,500 -204,800	-25%	-$6.55M	0.01%	832
2017 Q3	$30.6M	Buy	813,300 +518,365	+176%	+$16.9M	0.02%	593
2017 Q2	$8.23M	Sell	294,935 -11,694	-4%	-$349K	0.01%	1258
2017 Q1	$10.5M	Buy	306,629 +12,096	+4%	+$427K	0.01%	1095
2016 Q4	$8.49M	Sell	294,533 -2,526	-0.9%	-$66.8K	0.01%	1230
2016 Q3	$9.45K	Sell	297,059 -86,381	-23%	-$2.93M	0.01%	1158
2016 Q2	$12.4M	Buy	383,440 +19,138	+5%	+$640K	0.01%	943
2016 Q1	$10.2M	Buy	364,302 +3,393	+0.9%	+$74K	0.01%	1042
2015 Q4	$12.9M	Sell	360,909 -4,560	-1%	-$161K	0.01%	932
2015 Q3	$12.1M	Buy	365,469 +2,768	+0.8%	+$115K	0.01%	948
2015 Q2	$15.2M	Buy	362,701 +76,326	+27%	+$2.95M	0.01%	908
2015 Q1	$9.33M	Buy	286,375 +4,749	+2%	+$163K	0.01%	1192
2014 Q4	$8.94M	Sell	281,626 -33,244	-11%	-$943K	0.01%	1194
2014 Q3	$7.8M	Sell	314,870 -83,853	-21%	-$1.96M	0.01%	1274
2014 Q2	$9.01M	Buy	398,723 +3,398	+0.9%	+$70.9K	0.01%	1241
2014 Q1	$9.62M	Buy	395,325 +15,837	+4%	+$401K	0.01%	1165
2013 Q4	$9.48M	Sell	379,488 -6,756	-2%	-$159K	0.01%	1187
2013 Q3	$10.6M	Buy	386,244 +14,181	+4%	+$296K	0.01%	1055
2013 Q2	$6.75M	Buy	+372,063	New	+$5.12M	0.01%	1295